JPH0455425B2 - - Google Patents

Info

Publication number
JPH0455425B2
JPH0455425B2 JP60500432A JP50043285A JPH0455425B2 JP H0455425 B2 JPH0455425 B2 JP H0455425B2 JP 60500432 A JP60500432 A JP 60500432A JP 50043285 A JP50043285 A JP 50043285A JP H0455425 B2 JPH0455425 B2 JP H0455425B2
Authority
JP
Japan
Prior art keywords
compound
product
vitamin
compounds
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60500432A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61501147A (ja
Inventor
Hekutaa Efu Deruuka
Hainritsuhi Kee Shunoozu
Rafuaru Aaru Shishinsuki
Yoko Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UISUKONSHIN ARAMUNI RISAACHI FUAUNDEESHON
Original Assignee
UISUKONSHIN ARAMUNI RISAACHI FUAUNDEESHON
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UISUKONSHIN ARAMUNI RISAACHI FUAUNDEESHON filed Critical UISUKONSHIN ARAMUNI RISAACHI FUAUNDEESHON
Publication of JPS61501147A publication Critical patent/JPS61501147A/ja
Publication of JPH0455425B2 publication Critical patent/JPH0455425B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
JP60500432A 1984-01-30 1985-01-07 １α，２５−ジヒドロキシ−２２Ｚ−デヒドロビタミンＤ化合物 Granted JPS61501147A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57511484A 1984-01-30 1984-01-30
US575114 1984-01-30

Publications (2)

Publication Number Publication Date
JPS61501147A JPS61501147A (ja) 1986-06-12
JPH0455425B2 true JPH0455425B2 (en, 2012) 1992-09-03

Family

ID=24299012

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60500432A Granted JPS61501147A (ja) 1984-01-30 1985-01-07 １α，２５−ジヒドロキシ−２２Ｚ−デヒドロビタミンＤ化合物

Country Status (11)

Country Link
JP (1) JPS61501147A (en, 2012)
AU (1) AU587174B2 (en, 2012)
BE (1) BE901601A (en, 2012)
CH (1) CH665835A5 (en, 2012)
DE (2) DE3590021T (en, 2012)
DK (1) DK437685D0 (en, 2012)
FR (1) FR2558828B1 (en, 2012)
GB (1) GB2153358B (en, 2012)
IE (1) IE57936B1 (en, 2012)
NL (1) NL8520009A (en, 2012)
WO (1) WO1985003300A1 (en, 2012)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3590020T1 (de) * 1984-01-30 1986-01-23 Wisconsin Alumni Research Foundation, Madison, Wis. In der Seitenkette ungesättigte 1-Hydroxyvitamin D-Verbindungen
WO1985003939A1 (en) * 1984-03-05 1985-09-12 Wisconsin Alumni Research Foundation 1alpha-HYDROXYVITAMIN D2 ANALOGS AND PROCESS FOR PREPARING SAME
KR910004337B1 (ko) * 1985-01-17 1991-06-26 위스콘신 알럼니 리서치 화운데이션 비타민 d 유도체 및 이를 함유하는 약제
CA1333616C (en) * 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
NZ232734A (en) * 1989-03-09 1991-11-26 Wisconsin Alumni Res Found 19-nor vitamin d derivatives and pharmaceutical compositions
US5246925A (en) * 1989-03-09 1993-09-21 Wisconsin Alumni Research Foundation 19-nor-vitamin D compounds for use in treating hyperparathyroidism

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260549A (en) * 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
EP0015122B1 (en) * 1979-02-15 1983-09-14 Teijin Limited New 25-hydroxy-24-oxocholestane derivatives and preparation thereof
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same

Also Published As

Publication number Publication date
NL8520009A (nl) 1985-12-02
DE3590021C2 (de) 1992-09-10
BE901601A (fr) 1985-05-17
FR2558828A1 (fr) 1985-08-02
IE850213L (en) 1985-07-30
DK437685A (da) 1985-09-27
DE3590021T (de) 1986-01-23
GB8502161D0 (en) 1985-02-27
WO1985003300A1 (en) 1985-08-01
FR2558828B1 (fr) 1987-11-20
CH665835A5 (de) 1988-06-15
GB2153358B (en) 1987-07-22
DK437685D0 (da) 1985-09-27
JPS61501147A (ja) 1986-06-12
IE57936B1 (en) 1993-05-19
AU587174B2 (en) 1989-08-10
AU3837285A (en) 1985-08-09
GB2153358A (en) 1985-08-21

Similar Documents

Publication Publication Date Title
US4689180A (en) 1α,25-dihydroxy-22Z-dehydroxyvitamin D compound
US5585369A (en) Method of treating low bone turnover osteoporosis with (205) vitamin D compounds
JP2505713B2 (ja) ビタミンｄ−２２−フェニルスルホン誘導体
US4719205A (en) Side-chain unsaturated 1-hydroxyvitamin D compounds
AU565568B2 (en) 23, 23-difluoro-1 , 25-dihydroxy-vitamin d3
JPH0576940B2 (en, 2012)
JPH04505468A (ja) 同族化されたビタミンＤ↓２化合物および対応する１α―ヒドロキシル化誘導体
US4719204A (en) Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D2 analogs
WO1985003298A1 (en) Hydroxyvitamin d2 isomers
JPS6342618B2 (en, 2012)
JPH0314303B2 (en, 2012)
JPH0455425B2 (en, 2012)
JPH05222089A (ja) １α，３β，２５−トリヒドロキシ−２４−ホモコレスタ−５，２２−ジエン化合物
AU584071B2 (en) 1a-hydroxyvitamin d2 analogs and process for preparing same
EP0154627A1 (en) 23,23-difluoro-25-hydroxy-vitamin d 3? and process for preparing same
AU589113B2 (en) Side-chain unsaturated 1-hydroxyvitamin d compounds